Crossmark

Multi-method computational evaluation of the inhibitors against leucine-rich repeat kinase 2 G2019S mutant for Parkinson's disease

Published Online: 2024-02-23

Published Print: 2024-12

Authors

Elhadi, Ahmed

Zhao, Dan

Ali, Noman

Sun, Fusheng

Zhong, Shijun
License Information

Text and Data Mining valid from 2024-02-23

Version of Record valid from 2024-02-23
More Information

Article History

Received: 5 September 2023

Accepted: 7 January 2024

First Online: 23 February 2024

Declarations

:

: The authors have no relevant financial or nonfinancial interests to disclose.

Document is current